Group B streptococcal disease in infants: progress in prevention and continued challenges

Area of Science:

• Obstetrics and Gynecology
• Neonatal Medicine
• Infectious Disease Prevention

Background:

• Group B Streptococcus (GBS) causes early-onset neonatal sepsis.
• Prevention measures like universal screening and intrapartum antibiotic prophylaxis have reduced GBS disease burden.
• Despite progress, GBS remains the primary cause of early-onset neonatal sepsis in the US.

Purpose of the Study:

• To discuss implementation challenges for clinicians regarding revised guidelines for GBS prevention.
• To present an updated algorithm for neonatal management of GBS exposure.
• To address the ongoing impact of GBS on neonatal health.

Main Methods:

• Review of current prevention strategies for perinatal Group B Streptococcus.
• Analysis of implementation challenges faced by healthcare providers.
• Development of a revised neonatal management algorithm.

Main Results:

• Significant decrease in early-onset GBS disease over 20 years attributed to screening and prophylaxis.
• Identification of persistent challenges in implementing prevention measures.
• Establishment of an updated algorithm for neonatal care in response to GBS.

Conclusions:

• While prevention efforts have been successful, GBS remains a critical threat to newborns.
• Updated clinical guidelines and management algorithms are essential for continued progress.
• Effective implementation of prevention strategies requires addressing clinician challenges.